Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 10/20 | 0.40 |
| ▸ | CDC25B | P30305 | 9/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 6/20 | 0.40 |
| ▸ | PTPN6 | P29350 | 5/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | MDM4 | O15151 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.38 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.38 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.38 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12425693 | 0.86 | DRD2 (0.42) | CA1CA2CA9NT5EPTPN1 | |
| SCHEMBL13201198 | 0.86 | DRD2 (0.42) | CA1CA2CA9NT5EPTPN1 | |
| SCHEMBL19189222 | 0.80 | HTR1A (0.51) | CA1CA2CA9NT5EPTPN1 | |
| SCHEMBL19189070 | 0.80 | HTR1A (0.51) | CA1CA2CA9NT5EPTPN1 | |
| SCHEMBL12601466 | 0.79 | HTR1A (0.44) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL5275316 | 0.79 | PTPN1 (0.46) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL5526982 | 0.79 | HTR1A (0.44) | CA1CA2CA9NT5EPTPN1 | |
| SCHEMBL5271989 | 0.79 | HTR1A (0.44) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL5521002 | 0.78 | NT5E (0.48) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL5272589 | 0.78 | PTPN1 (0.42) | CA1CA2CA9NT5EPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070161787-A1 | C-glycoside derivatives and salts thereof | ASTELLAS PHARMA INC. (JP) | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161787-A1 | C-glycoside derivatives and salts thereof | SLC5A1, SLC5A2, SLC2A1 | CA1 1852/4885CA2 265/4885CA9 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.